cysteamine has been researched along with Diabetes Mellitus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buya, M; Chen, J; Dong, X; Guo, Q; Kang, M; Lu, W; Qin, W; Wu, Y; Zheng, W | 1 |
1 other study(ies) available for cysteamine and Diabetes Mellitus
Article | Year |
---|---|
VNN1, a potential biomarker for pancreatic cancer-associated new-onset diabetes, aggravates paraneoplastic islet dysfunction by increasing oxidative stress.
Topics: Adenocarcinoma; Aged; Amidohydrolases; Animals; Biomarkers; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cysteamine; Diabetes Mellitus; Female; Glutathione; GPI-Linked Proteins; Humans; Islets of Langerhans; Mice; Middle Aged; Oxidative Stress; Pancreatic Neoplasms; Paraneoplastic Syndromes; PPAR gamma | 2016 |